FDA Approved: FAMOTIDINE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings, Inc.'s original ANDA for famotidine, allowing the generic version to enter the market. Famotidine is an H2 blocker used to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Famotidine (famotidine)

Snippet

ORIG AP for FAMOTIDINE (FAMOTIDINE)